Purple Biotech (PPBT) Shares Outstanding (2018 - 2025)

Purple Biotech (PPBT) has 8 years of Shares Outstanding data on file, last reported at $1.9 billion in Q4 2025.

• Shares Outstanding for Q4 2025 came in at $1.9 billion, up 259.47% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.9 billion (up 259.47% YoY), and the FY2025 annual result was $1.9 billion, up 259.47% from the prior year.
• Shares Outstanding grew to $1.9 billion in Q4 2025 per PPBT's latest filing, from $517.1 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $1.9 billion in Q4 2025 and troughed at $178.0 million in Q4 2021.
• A 5-year average of $598.2 million and a median of $252.4 million in 2023 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding jumped 934.25% in 2021, then rose 3.83% in 2022.
• A 5-year view of Shares Outstanding shows it stood at $178.0 million in 2021, then increased by 3.83% to $184.8 million in 2022, then soared by 36.56% to $252.4 million in 2023, then surged by 104.9% to $517.1 million in 2024, then jumped by 259.47% to $1.9 billion in 2025.
• Business Quant data shows PPBT's Shares Outstanding at $1.9 billion in Q4 2025, $517.1 million in Q4 2024, and $252.4 million in Q4 2023.